C185140Level 2

Retired Concept 2021

**Semantic type:** Conceptual Entity

GET/api/v1/systems/nci_thesaurus/nodes/C185140

Official DownloadCC BY 4.0Source

Hierarchy Explorer

Hierarchy ExplorerChevron to expand - click title to open

C105615ALK Inhibitor RO5424802

C105619As Bad as You Can Imagine

C106055MethylC-Seq

C107241ERK Inhibitor GDC-0994

C107500Iodine I 124 Phospholipid Ether Analogue CLR1404

C113120Hepatitis C RNA Measurement

C116779Spondylitis

C118276Have Gained Weight

C118568PI3K Inhibitor ACP-319

C118601Able to Do Usual Activities

C1201935-Alpha-Reductase Deficiency

C121535Gamma-Secretase Inhibitor LY3039478

C125007Histopathology Result

C126481High Grade Broad Ligament Serous Adenocarcinoma

C127905Cervical Mucinous Adenocarcinoma, Gastric Type

C132173Bcr-Abl Kinase Inhibitor K0706

C136424CSF1R Inhibitor DCC-3014

C140354Amcenestrant

C147534Anti-CD3/Anti-GPRC5D Bispecific Monoclonal Antibody JNJ-64407564

C153211Anti-HER2/Anti-HER3 Bispecific Monoclonal Antibody MCLA-128

C153613Recurrent Fallopian Tube Serous Adenocarcinoma

C153817Recurrent Malignant Ovarian Transitional Cell Tumor

C155787Cognitive Behavior Therapy for Insomnia

C155886Ciclopirox Prodrug CPX-POM

C156773EGFR Mutant-specific Inhibitor D-0316

C157282Acapatamab

C158095Anti-PD-L1 Monoclonal Antibody TG-1501

C158984GDC Adverse Event Terminology

C158985GDC AJCC Clinical M Terminology

C158986GDC AJCC Clinical N Terminology

C158987GDC AJCC Clinical Stage Terminology

C158988GDC AJCC Clinical T Terminology

C158989GDC AJCC Pathologic M Terminology

C158990GDC AJCC Pathologic N Terminology

C158991GDC AJCC Pathologic Stage Terminology

C158992GDC AJCC Pathologic T Terminology

C158993GDC AJCC Staging System Edition Terminology

C158994GDC Alcohol History Terminology

C158995GDC Alcohol Intensity Terminology

C158996GDC Analyte Type ID Terminology

C158997GDC Analyte Type Terminology

C158998GDC Anaplasia Present Terminology

C158999GDC Anaplasia Present Type Terminology

C159000GDC Ann Arbor B Symptoms Terminology

C159001GDC Ann Arbor Clinical Stage Terminology

C159002GDC Ann Arbor Extranodal Involvement Terminology

C159003GDC Ann Arbor Pathologic Stage Terminology

C159004GDC Antigen Terminology

C159005GDC Asbestos Exposure Terminology

C159006GDC Barretts Esophagus Goblet Cells Present Terminology

C159007GDC Best Overall Response Terminology

C159008GDC Biospecimen Anatomic Site Terminology

C159009GDC Biospecimen Laterality Terminology

C159010GDC Biospecimen Type Terminology

C159011GDC Burkitt Lymphoma Clinical Variant Terminology

C159012GDC Cause of Death Terminology

C159013GDC Child Pugh Classification Terminology

C159014GDC Chromosome Terminology

C159015GDC Classification of Tumor Terminology

C159016GDC COG Liver Stage Terminology

C159017GDC COG Neuroblastoma Risk Group Terminology

C159018GDC COG Renal Stage Terminology

C159019GDC COG Rhabdomyosarcoma Risk Group Terminology

C159020GDC Comorbidity Method of Diagnosis Terminology

C159021GDC Comorbidity Terminology

C159022GDC Composition Terminology

C159023GDC Data Category Terminology

C159024GDC Data Format Terminology

C159025GDC Data Type Terminology

C159026GDC Diabetes Treatment Type Terminology

C159027GDC Diagnosis Pathologically Confirmed Terminology

C159028GDC Disease Response Terminology

C159029GDC Disease Type Terminology

C159030GDC Distance Normal to Tumor Terminology

C159031GDC ECOG Performance Status Terminology

C159032GDC Enneking MSTS Grade Terminology

C159033GDC Enneking MSTS Metastasis Terminology

C159034GDC Enneking MSTS Stage Terminology

C159035GDC Enneking MSTS Tumor Site Terminology

C159036GDC Esophageal Columnar Dysplasia Degree Terminology

C159037GDC Esophageal Columnar Metaplasia Present Terminology

C159038GDC Ethnicity Terminology

C159039GDC Experimental Strategy Terminology

C159040GDC FIGO Stage Terminology

C159041GDC First Symptom Prior to Diagnosis Terminology

C159042GDC Gastric Esophageal Junction Involvement Terminology

C159043GDC Gender Terminology

C159044GDC Gene Symbol Terminology

C159045GDC Goblet Cells Columnar Mucosa Present Terminology

C159046GDC Hepatitis Sustained Virological Response Terminology

C159047GDC Histone Family Terminology

C159048GDC Histone Variant Terminology

C159049GDC HPV Positive Type Terminology

C159050GDC Index Date Terminology

C159051GDC Initial Disease Status Terminology

C159052GDC INPC Grade Terminology

C159053GDC INPC Histologic Group Terminology

C159054GDC INRG Stage Terminology

C159055GDC INSS Stage Terminology

C159056GDC Instrument Model Terminology

C159057GDC IRS Group Terminology

C159058GDC IRS Stage Terminology

C159059GDC Ishak Fibrosis Score Terminology

C159060GDC ISS Stage Terminology

C159061GDC Karnofsky Performance Status Terminology

C159062GDC Laboratory Test Terminology

C159063GDC Last Known Disease Status Terminology

C159064GDC Laterality Terminology

C159065GDC Library Selection Terminology

C159066GDC Library Strand Terminology

C159067GDC Library Strategy Terminology

C159068GDC Lost to Follow-Up Terminology

C159069GDC Lymphatic Invasion Present Terminology

C159070GDC Medulloblastoma Molecular Classification Terminology

C159071GDC Menopause Status Terminology

C159072GDC Metastasis at Diagnosis Site Terminology

C159073GDC Metastasis at Diagnosis Terminology

C159074GDC Method of Diagnosis Terminology

C159075GDC Method of Sample Procurement Terminology

C159076GDC Micropapillary Features Terminology

C159077GDC Mismatch Repair Mutation Terminology

C159078GDC Mitosis Karyorrhexis Index Terminology

C159079GDC Molecular Analysis Method Terminology

C159080GDC Molecular Consequence Terminology

C159081GDC Morphology Terminology

C159082GDC Normal Tumor Genotype SNP Match Terminology

C159083GDC Perineural Invasion Present Terminology

C159084GDC Peripancreatic Lymph Nodes Positive Terminology

C159085GDC Platform Terminology

C159086GDC Ploidy Terminology

C159087GDC Premature at Birth Terminology

C159088GDC Preservation Method Terminology

C159089GDC Primary Diagnosis Terminology

C159090GDC Primary Site Terminology

C159091GDC Prior Malignancy Terminology

C159092GDC Prior Treatment Terminology

C159093GDC Progression or Recurrence Anatomic Site Terminology

C159094GDC Progression or Recurrence Terminology

C159095GDC Progression or Recurrence Type Terminology

C159096GDC Race Terminology

C159097GDC Radon Exposure Terminology

C159098GDC Read Pair Number Terminology

C159099GDC Reflux Treatment Terminology

C159100GDC Reflux Treatment Type Terminology

C159101GDC Relationship Gender Terminology

C159102GDC Relationship Primary Diagnosis Terminology

C159103GDC Relationship Type Terminology

C159104GDC Relative with Cancer History Terminology

C159105GDC Residual Disease Terminology

C159106GDC Risk Factor Terminology

C159107GDC Risk Factor Treatment Terminology

C159108GDC Sample Type ID Terminology

C159109GDC Sample Type Terminology

C159110GDC Second Gene Symbol Terminology

C159111GDC Site of Resection or Biopsy Terminology

C159112GDC Supratentorial Localization Terminology

C159113GDC Synchronous Malignancy Terminology

C159114GDC Target Capture Kit Terminology

C159115GDC Test Analyte Type Terminology

C159116GDC Test Result Terminology

C159117GDC Tissue or Organ of Origin Terminology

C159118GDC Tissue Type Terminology

C159119GDC Tobacco Smoking Status Terminology

C159120GDC Treatment Anatomic Site Terminology

C159121GDC Treatment Effect Terminology

C159122GDC Treatment Intent Type Terminology

C159123GDC Treatment or Therapy Terminology

C159124GDC Treatment Outcome Terminology

C159125GDC Treatment Type Terminology

C159126GDC Tumor Code ID Terminology

C159127GDC Tumor Code Terminology

C159128GDC Tumor Confined to Organ of Origin Terminology

C159129GDC Tumor Descriptor Terminology

C159130GDC Tumor Focality Terminology

C159131GDC Tumor Grade Terminology

C159132GDC Tumor Regression Grade Terminology

C159133GDC Type Terminology

C159134GDC Variant Type Terminology

C159135GDC Vascular Invasion Present Terminology

C159136GDC Vascular Invasion Type Terminology

C159137GDC Viral Hepatitis Serologies Terminology

C159138GDC Vital Status Terminology

C159139GDC Wilms Tumor Histologic Subtype Terminology

C159140GDC Zygosity Terminology

C163448Glycocholic Acid Measurement

C163973GDC Cause of Death Source Terminology

C164043GDC Ovarian Specimen Status Terminology

C164056GDC Type of Smoke Exposure Terminology

C164138GDC Time Between Waking and First Smoke Terminology

C164237GDC International Prognostic Index Terminology

C166390GDC Gleason Grade Group Terminology

C166392GDC Masaoka Stage Terminology

C166397GDC Primary Gleason Grade Terminology

C166404GDC Secondary Gleason Grade Terminology

C167296Ability to Carry Shopping Bag or Briefcase

C167355GDC Non Nodal Regional Disease Terminology

C167356GDC Non Nodal Tumor Deposits Terminology

C167357GDC Ovarian Surface Involvement Terminology

C167358GDC Pathogenicity Terminology

C167359GDC Peritoneal Fluid Cytological Status Terminology

C167367GDC Respirable Crystalline Silica Exposure Terminology

C167371GDC Coal Dust Exposure Terminology

C167372GDC Environmental Tobacco Smoke Exposure Terminology

C167373GDC Largest Extrapelvic Peritoneal Focus Terminology

C167374GDC Smoking Frequency Terminology

C167376GDC Type of Tobacco Used Terminology

C167377GDC Variant Origin Terminology

C168612GDC IGCCCG Stage Terminology

C169836Cemdisiran

C171018Refractory Fallopian Tube Serous Adenocarcinoma

C171104GDC Consent Type Terminology

C171105GDC Country of Residence at Enrollment

C171106GDC Gleason Grade Tertiary Terminology

C171107GDC Lymph Node Involved Site Terminology

C171108GDC Papillary Renal Cell Type

C171109GDC Pregnant at Diagnosis Terminology

C171110GDC Pregnancy Outcome Terminology

C171111GDC Transglottic Extension Terminology

C171112GDC Exposure Duration Terminology

C171113GDC Exposure Type Terminology

C171114GDC Secondhand Smoke as Child

C171115GDC Adverse Event Grade Terminology

C171116GDC AIDS Risk Factors Terminology

C171117GDC CDC HIV Risk Factors Terminology

C171118GDC Evidence of Recurrence Type Terminology

C171119GDC HAART Treatment Indicator Terminology

C171120GDC Hormonal Contraceptive Use Terminology

C171121GDC Hysterectomy Type Terminology

C171122GDC Imaging Type Terminology

C171123GDC Immunosuppressive Treatment Type Terminology

C171124GDC Scan Tracer Used Terminology

C171125GDC Bone Marrow Malignant Cells Terminology

C171126GDC Chemotherapy Concurrent to Radiation Terminology

C171127GDC Reason Treatment Ended Terminology

C171129GDC Treatment Effect Indicator Terminology

C171130GDC Treatment Frequency Terminology

C171153GDC Stain Type Terminology

C171287GDC Treatment Dose Units Terminology

C171332GDC Margins Involved Site Terminology

C171333GDC Hysterectomy Margins Involved Terminology

C172185GDC Imaging Result Terminology

C172228GDC Clonality Terminology

C172294GDC Tissue Collection Type Terminology

C173264CNS Involvement at Leukemia Diagnosis

C173521CNS Status/Disease Status

C173646GDC Columnar Mucosa Present Terminology

C173647GDC Alcohol Type Terminology

C173666GDC Chipseq Target Terminology

C173667GDC Dysplasia Degree Terminology

C173668GDC Dysplasia Type Terminology

C173669GDC ELN Risk Classification Terminology

C173670GDC Hormonal Contraceptive Type

C173671GDC Hormone Replacement Therapy Type

C173672GDC Lymph Node Involvement Terminology

C173673GDC Margin Status Terminology

C173674GDC Metaplasia Present Terminology

C173675GDC Morphologic Architectural Pattern Terminology

C173676GDC Procedures Performed Terminology

C173677GDC Satellite Nodule Present Terminology

C173678GDC WHO CNS Grade Terminology

C174339Mycolicibacterium mucogenicum

C175005Age in Days at Laboratory Test

C175801Inupadenant

C176761Thyroid Peroxidase Antibody Measurement

C178070Interim Maintenance Therapy Duplicate1

C178078Interim Maintenance Therapy Duplicate2

C178378Genetic Predisposition to Cancer

C178385ETV6-Related Predisposition to Leukemia

C179107Nezulcitinib

C180701Primary Immune Thrombocytopenia

C27378Adult Myxoid Chondrosarcoma

C28327Endocervical Carcinoma

C2996Dysgerminoma

C32054Alveolar Cell Type I

C32352Common Carotid Artery

C32457Desmoplakin

C33044Macula Lutea

C33167Neurofilament-H

C33168Neurofilament-L

C33169Neurofilament-M

C35934Locally Metastatic Malignant Neoplasm

C40087Benign Ovarian Transitional Cell Tumor

C40088Borderline Ovarian Transitional Cell Tumor

C40089Malignant Ovarian Transitional Cell Tumor

C40092Ovarian Squamous Cell Tumor

C40117Tubal Epithelial Hyperplasia

C40202Cervical Mucinous Adenocarcinoma, Endocervical-Type

C40257Vaginal Tubular Adenoma

C40288Vulvar Squamous Cell Carcinoma, Keratoacanthoma Type

C4250Well Differentiated Liposarcoma

C4294Benign Mesonephroma

C4295Mesonephric Neoplasm

C4303Myxoid Chondrosarcoma

C4501Malignant Lipomatous Neoplasm

C4654Atypical Endometrial Hyperplasia

C52722Long Bone Epiphysis

C53346Death Rate

C66951Adenocarcinoma, Endocervical Type

C66953Mucinous Adenocarcinoma, Endocervical Type

C7280Ovarian Transitional Cell Tumor

C75007Marfan Syndrome Type II

C77956Forestomach

C79102HIV Measurement

C84859DEC-205/NY-ESO-1 Fusion Protein CDX-1401

C88313Polo-like Kinase 1 Inhibitor NMS-1286937

C99637iodine I 131 Iopofosine

Cross-system equivalences0

No cross-system equivalences mapped for this node.

Report a data issue